Navigation Links
Sunesis to Present at the Jefferies 3rd Annual Healthcare Conference
Date:6/16/2009

SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the Jefferies 3rd Annual Healthcare Conference at 10:45 a.m. Eastern Time in New York on June 17, 2009.

The live webcast of this presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing voreloxin in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc. 

    Investor Contact:                           Media Contact:
    Sunesis Pharmaceuticals, Inc.               Sunesis Pharmaceuticals, Inc.
    Eric Bjerkholt                              Dan Weinseimer
    650-266-3717                                650-266-3739


'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
2. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
4. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
5. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
6. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
7. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
8. Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
9. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
10. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
11. Sunesis to Present at Upcoming Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...EGO, Nov. 20 Veridiam (www.veridia...d-size company category at the 2009 Workplace Exce... Diego Society for Human Resources Management and ...es practices. ,, Veridiam was one of nine winne... companies, honored at the recent awards ceremony....
(Date:11/20/2009)... METTLER TOLEDO recently announced that a ...timization Using At-Line Particle Characterization...n this webinar, the application of in situ particl...gn space and optimize a series of roller compactio...d roller compaction forces. , ...
(Date:11/19/2009)...LT, N.Y., Nov. 19 Dr. Mate Hidvegi... responds to a press release issued on November 17...pany for making false and self-serving statements ..., Dr. Hidvegi stated from his office in Budapes...arch on Avemar does not apply to AveULTRA, www.a...
(Date:11/19/2009)... MUNSTER, Germany, November 19 MON...on November 16th, 2009 Flibanserin in the,indicati...in Parkinson,s,disease for orphan drug status desi... Levodopa-induced dyskinesia is a complication of ... a serious burden to some of those,affected, since...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
... many ways, Promega Corp . has given Northwester...ny. , ,Quiet to those outside the life-science rea...uburban Madison walls, it,s anything but silent, a... far, that innovation has produced about 200 paten...g 130 new product innovations since 2002. , ,That ...
...tructure has always been important to the economic...infrastructure has traditionally been viewed as tr... highways, water, and power (electricity). Today, ... network infrastructure and the ability to have br...as you would not locate your company on some back ...
...embly Speaker Mike Huebsch , R-West Salem, and St... eight legislators to serve on the Speaker,s Task ...ipartisan task force is charged with exploring a n... state government, and learning from successful pr...dition to Montgomery, who will serve as chair of t...
Other Biology Technology:Promega Corporation: Wisconsin's quiet innovator 2Promega Corporation: Wisconsin's quiet innovator 3Promega Corporation: Wisconsin's quiet innovator 4Promega Corporation: Wisconsin's quiet innovator 5States need to be more "connectivity conscious" 2States need to be more "connectivity conscious" 3States need to be more "connectivity conscious" 4Eight lawmakers named to Speaker's IT task force 2
(Date:11/20/2009)...With the introduction of a single bacterial gene i...chnology in the Netherlands achieved three improve...aste material: ,More ethanol, less acetate and eli...ek the invention was published in the scientific j..., Car fuel , Bioethanol is made by the yeast ...
(Date:11/20/2009)... This release is available in German . , In...cal Investigation , Dr. Stefanie Eyerich and Dr. K...Imperial College London and Istituto Dermopatico d...ng discovery. It represents a milestone on the way...ory skin diseases such as psoriasis and allergic r...
(Date:11/20/2009)...Chronic obstructive pulmonary disease (COPD), a re...itis or emphysema, is the fourth leading cause of ...D and while researchers have yet to find any real ...ch Institute at The University of Western Ontario ...ques to gain new insight into the disease. , ...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Gaining a better picture of lung disease 2Heat forms potentially harmful substance in high fructose corn syrup 10357 1As More Cyclists Hit the Road Serious Injuries Rise 59456 1As More Cyclists Hit the Road Serious Injuries Rise 59456 2Choyce Peterson Goes the Extra Mile for Visiting Nurses 59452 1Choyce Peterson Goes the Extra Mile for Visiting Nurses 59452 2
...n ocean-bottom rocks are more abundant and diverse...he planet,s oceanic crust, according to results of...nal Nature. , The findings pose intriguing quest... Earth and life. , Once considered a barren plain...cky regions appear to be teeming with microbial li...
...loor, microbial life is feeding on fresh volcanic ...ven the most optimistic scientists thought possibl...urnal Nature, scientists have found bacteria growi...usands- to ten-thousand times (three to four order...overlying waters. , Researchers from the Woods H...
...A naturally occurring molecule made by symbiotic g...inflammatory bowel disease, according to scientist...Most people tend to think of bacteria as insidious... Mazmanian, an assistant professor of biology at C...lationship between "good" bacteria and their mamma...
Other Biology News:Bacteria 'feed' on earth's ocean-bottom crust 2Scientists find bacteria thriving on a feast of seafloor rock 2Getting better with a little help from our 'micro' friends 2Getting better with a little help from our 'micro' friends 3
Hoagland's No. 2 Basal Salt Mixture from Sigma-Aldrich
Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
...00 Q TRAP(TM) LC/MS/MS System, a high performance ...trometer for the drug discovery, drug development ...ap (LIT) Technology from the leaders in mass spect...e analysis with the proven, high sensitivity quant...
Dulbecco's Modified Eagle's Medium - high glucose (DME) from Sigma-Aldrich
Biology Products: